BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21620584)

  • 41. Doses delivered by portal imaging quality assurance in routine practice of adjuvant breast radiotherapy worth to by monitored and compensated in some cases.
    Kefs S; Giraud JY; Naud J; Henry I; Gabelle-Flandin I; Balosso J; Chaikh A; Verry C
    Quant Imaging Med Surg; 2021 Aug; 11(8):3481-3493. PubMed ID: 34341725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Preliminary Simulation Study of Dose-Guided Adaptive Radiotherapy Based on Halcyon MV Cone-Beam CT Images With Retrospective Data From a Phase II Clinical Trial.
    Huang Y; Wang H; Li C; Hu Q; Liu H; Deng J; Li W; Wang R; Wu H; Zhang Y
    Front Oncol; 2020; 10():574889. PubMed ID: 33134173
    [No Abstract]   [Full Text] [Related]  

  • 43. Dose tracking assessment for image-guided radiotherapy of the prostate bed and the impact on clinical workflow.
    Orlandini LC; Coppola M; Fulcheri C; Cernusco L; Wang P; Cionini L
    Radiat Oncol; 2017 Apr; 12(1):78. PubMed ID: 28454559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of daily imaging on plan quality and normal tissue toxicity for prostate cancer radiotherapy.
    Bell K; Heitfeld M; Licht N; Rübe C; Dzierma Y
    Radiat Oncol; 2017 Jan; 12(1):7. PubMed ID: 28069053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between patients' anatomical characteristics and interfractional internal prostate motion during intensity modulated radiation therapy for prostate cancer.
    Maruoka S; Yoshioka Y; Isohashi F; Suzuki O; Seo Y; Otani Y; Akino Y; Takahashi Y; Sumida I; Ogawa K
    Springerplus; 2015; 4():579. PubMed ID: 26543714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Image quality and dose distributions of three linac-based imaging modalities.
    Dzierma Y; Ames E; Nuesken F; Palm J; Licht N; Rübe C
    Strahlenther Onkol; 2015 Apr; 191(4):365-74. PubMed ID: 25527311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peripheral dose heterogeneity due to the thread effect in total marrow irradiation with helical tomotherapy.
    Takahashi Y; Verneris MR; Dusenbery KE; Wilke CT; Storme G; Weisdorf DJ; Hui SK
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):832-9. PubMed ID: 24011657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of imaging performance of megavoltage cone-beam CT over an extended period.
    Sumida I; Yamaguchi H; Kizaki H; Yamada Y; Koizumi M; Yoshioka Y; Ogawa K; Kakimoto N; Murakami S; Furukawa S
    J Radiat Res; 2014 Jan; 55(1):191-9. PubMed ID: 23979076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current status of intensity-modulated radiation therapy for prostate cancer: History, clinical results and future directions.
    Hatano K; Tohyama N; Kodama T; Okabe N; Sakai M; Konoeda K
    Int J Urol; 2019 Aug; 26(8):775-784. PubMed ID: 31115116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of the bowel and bladder preparation protocol for radiotherapy of prostate cancer using kilo-voltage cone beam CT: Our experience.
    Heng SP; Low SH; Sivamany K
    Indian J Cancer; 2015; 52(4):639-44. PubMed ID: 26960504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer.
    Akino Y; Koizumi M; Sumida I; Takahashi Y; Ogata T; Ota S; Isohashi F; Konishi K; Yoshioka Y
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1715-22. PubMed ID: 21620584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
    Qin A; Sun Y; Liang J; Yan D
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testicular doses in image-guided radiotherapy of prostate cancer.
    Deng J; Chen Z; Yu JB; Roberts KB; Peschel RE; Nath R
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e39-47. PubMed ID: 21489702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimation of rectal dose using daily megavoltage cone-beam computed tomography and deformable image registration.
    Akino Y; Yoshioka Y; Fukuda S; Maruoka S; Takahashi Y; Yagi M; Mizuno H; Isohashi F; Ogawa K
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):602-8. PubMed ID: 24074934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer.
    Davidson MT; Blake SJ; Batchelar DL; Cheung P; Mah K
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1550-8. PubMed ID: 21543164
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.